The bronchodilator response in preschool children: A systematic review

Emma Raywood1, Sooky Lum1, Paul Aurora1,2

  • 1Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.

Insights

Bronchodilator response testing in preschool children lacks strong evidence. Spirometry is unreliable, and further research on alternative methods is needed for diagnosing wheezing in this age group.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Diagnostics

Background:

  • Bronchodilator response (BDR) testing is commonly used for diagnosing and treating wheezing in children.
  • Limited evidence exists for BDR's role in preschool children, with uncertainty regarding adult-derived cut-off values.
  • Preschool children present unique challenges for respiratory assessments.

Purpose of the Study:

  • To review the evidence for bronchodilator response testing in preschool children with wheezing.
  • To evaluate the applicability of existing BDR cut-off values to this population.
  • To identify optimal BDR techniques for preschool children.

Main Methods:

  • A systematic literature search was conducted across major databases (MEDLINE, EMBASE, Web of Science, Cochrane).
  • Studies included were those reporting BDR in healthy preschool children, placebo response, and diagnostic efficacy compared to clinical diagnosis.
  • Data from 14 studies were analyzed, focusing on BDR measurements and technique success rates.

Main Results:

  • Spirometry-based BDR showed limited clinical utility in preschool children with wheezing.
  • Alternative techniques like interrupter resistance, oscillometry, and plethysmography were more consistently completed.
  • Significant heterogeneity between studies prevented the determination of an optimal BDR technique.

Conclusions:

  • Current evidence does not strongly support the use of spirometry-based BDR for assessing preschool children with wheezing.
  • Further research is needed to evaluate simpler, alternative BDR techniques in this age group.
  • Future studies should focus on children with suspected airway disease and assess BDR's predictive value for treatment response.
Abstract

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.0K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
968
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K